Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma (Q37322196)

19 August 2017

Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma (English)

1 reference

adaptive radiation therapy

19 August 2017

0 references

Rebecca D Dodd

0 references

Ralph Weissleder

1 reference

19 August 2017

Tyler Jacks

1 reference

19 August 2017

David G Kirsch

1 reference

19 August 2017

Sam S Yoon

1 reference

19 August 2017

Lars Stangenberg

1 reference

19 August 2017

G Petur Nielsen

1 reference

19 August 2017

Umar Mahmood

1 reference

19 August 2017

Yoon-Jin Lee

1 reference

19 August 2017

Courtney Rothrock

1 reference

19 August 2017

Jonathan M Dreyfuss

1 reference

19 August 2017

Kwan-Hyuck Baek

1 reference

19 August 2017

Peter R Waterman

1 reference

19 August 2017

Peter J Park

1 reference

19 August 2017

Carolyn J Fisher

1 reference

19 August 2017

Sandra Ryeom

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

International Journal of Radiation Oncology Biology Physics

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

1207-1216

1 reference

Radiation therapy plus angiogenesis inhibition with bevacizumab: rationale and initial experience

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Therapeutic nanoparticles for drug delivery in cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Molecular basis for sunitinib efficacy and future clinical development

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Tomographic fluorescence imaging of tumor vascular volume in mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Harnessing preclinical mouse models to inform human clinical cancer trials.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Cyclin-dependent kinase-inhibitor 1 (CDKN1A) in the squamous epithelium of the oropharynx: possible implications of molecular biology and compartmentation.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

TORC1 is essential for NF1-associated malignancies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Angiogenic profile of soft tissue sarcomas based on analysis of circulating factors and microarray gene expression.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

A spatially and temporally restricted mouse model of soft tissue sarcoma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733223

Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19545786

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.IJROBP.2009.02.052

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19545786

1 reference